NL192924C - ß-Lactamverbindingen met anti-biotische werking en bereiding daarvan. - Google Patents

ß-Lactamverbindingen met anti-biotische werking en bereiding daarvan. Download PDF

Info

Publication number
NL192924C
NL192924C NL8100571A NL8100571A NL192924C NL 192924 C NL192924 C NL 192924C NL 8100571 A NL8100571 A NL 8100571A NL 8100571 A NL8100571 A NL 8100571A NL 192924 C NL192924 C NL 192924C
Authority
NL
Netherlands
Prior art keywords
amino
oxo
sulfonic acid
solution
methyl
Prior art date
Application number
NL8100571A
Other languages
English (en)
Dutch (nl)
Other versions
NL192924B (nl
NL8100571A (nl
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL8100571A publication Critical patent/NL8100571A/nl
Publication of NL192924B publication Critical patent/NL192924B/xx
Application granted granted Critical
Publication of NL192924C publication Critical patent/NL192924C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
NL8100571A 1980-02-07 1981-02-06 ß-Lactamverbindingen met anti-biotische werking en bereiding daarvan. NL192924C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11927680A 1980-02-07 1980-02-07
US11927680 1980-02-07
US18889380A 1980-09-29 1980-09-29
US18889380 1980-09-29

Publications (3)

Publication Number Publication Date
NL8100571A NL8100571A (nl) 1981-09-01
NL192924B NL192924B (nl) 1998-01-05
NL192924C true NL192924C (nl) 1998-05-07

Family

ID=26817179

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100571A NL192924C (nl) 1980-02-07 1981-02-06 ß-Lactamverbindingen met anti-biotische werking en bereiding daarvan.

Country Status (29)

Country Link
JP (3) JPS56125362A (de)
KR (1) KR860001289B1 (de)
AR (1) AR245932A1 (de)
AU (1) AU569407B2 (de)
CA (1) CA1338670C (de)
CH (2) CH653993A5 (de)
DD (1) DD156180A5 (de)
DE (1) DE3104145C2 (de)
DK (1) DK166280C (de)
ES (1) ES8205397A1 (de)
FI (1) FI80271C (de)
FR (1) FR2509299B1 (de)
GB (2) GB2071650B (de)
GR (1) GR74151B (de)
HK (1) HK57785A (de)
IE (2) IE51392B1 (de)
IL (1) IL62082A (de)
IT (1) IT1135360B (de)
KE (1) KE3539A (de)
LU (1) LU83117A1 (de)
MY (1) MY8600179A (de)
NL (1) NL192924C (de)
NO (2) NO161065C (de)
NZ (2) NZ196202A (de)
PH (3) PH24729A (de)
PT (1) PT72465B (de)
SE (3) SE457954B (de)
SG (1) SG39185G (de)
YU (1) YU44829B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050965A1 (de) * 1980-10-23 1982-05-05 Takeda Chemical Industries, Ltd. Beta-Lactamase inhibierende Zusammensetzung
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4673739A (en) * 1980-12-05 1987-06-16 Takeda Chemical Industries, Ltd. 4-carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
JPS57131758A (en) * 1980-12-05 1982-08-14 Takeda Chem Ind Ltd 1-sulfo-2-oxoazetidine derivative, its preparation and use
WO1983000690A1 (en) * 1981-08-25 1983-03-03 Takeda Chemical Industries Ltd Azetidine derivatives and process for their preparation
US4675397A (en) * 1980-12-05 1987-06-23 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
MX7096E (es) * 1980-12-05 1987-06-19 Takeda Chemical Industries Ltd Metodo para preparacion de derivados de 2-oxoazetidina
JPS58210061A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 1−スルホ−2−オキソアゼチジン誘導体、その製造法および用途
US4782147A (en) * 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
CA1181075A (en) * 1981-07-13 1985-01-15 David M. Floyd CRYSTALLINE ANHYDROUS FORM OF [3-S-[3.alpha.(Z),4 .beta.]]-3-[[(2-AMINO-4-THIAZOLYL) [(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL] AMINO]-4-METHYL-2-OXO-1-AZETIDINESULFONIC ACID
FR2515182B1 (fr) * 1981-10-23 1986-05-09 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
FR2538389B2 (fr) * 1981-10-23 1986-05-16 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine-1-sulfamique, nouveau procede de preparation de produits optiquement actifs, application des nouveaux produits comme medicaments et produits necessaires a leur preparation
IL67451A (en) * 1981-12-25 1987-10-20 Takeda Chemical Industries Ltd 4-cyano-2-azetidinones and production thereof and process for the preparation of 4-carbamoyl-2-azetidinones using them
EP0088488B1 (de) * 1982-01-22 1986-10-01 Beecham Group Plc Antibakteriell wirkende Mittel, ihre Herstellung und Verwendung
EP0086563A1 (de) * 1982-01-22 1983-08-24 Beecham Group Plc Antibakteriel wirkende Mittel, ihre Herstellung und Verwendung
US4443374A (en) * 1982-02-01 1984-04-17 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]-acetyl]amino]-2-oxo-1-azetidinesulfonic acid, and 4-substituted derivatives
WO1983002942A1 (en) * 1982-02-19 1983-09-01 Yoshioka, Kouichi Process for preparing 2-azetidinone-1-sulfonic acids, and starting materials therefor
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
EP0096296B1 (de) * 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
DE3377061D1 (en) * 1982-06-03 1988-07-21 Hoffmann La Roche Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
US4704457A (en) * 1982-06-21 1987-11-03 E. R. Squibb & Sons, Inc. Process for the preparation of (3S)-3-[[[2-(protected amino)-4-thiazolyl]-oxoacetyl]amino]-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives thereof
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
US4681937A (en) * 1982-09-27 1987-07-21 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters
US4551276A (en) * 1982-10-06 1985-11-05 E. R. Squibb & Sons, Inc. 2-Oxoazetidin-1-yloxymethyl sulfonic acid and analogs
US4533495A (en) * 1982-12-30 1985-08-06 Takeda Chemical Industries, Ltd. Method of producing 2-azetidinone-1-sulfonic acid compounds
US4548747A (en) * 1983-05-02 1985-10-22 E. R. Squibb & Sons, Inc. 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones
US4652651A (en) * 1983-05-31 1987-03-24 Hoffmann-La Roche Inc. Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage
US4670554A (en) * 1983-05-31 1987-06-02 E. R. Squibb & Sons, Inc. ((3-Acylamino-2-oxo-1-azetidinyl)oxy)methyl)phosphinic acids
US4501697A (en) * 1983-06-17 1985-02-26 E. R. Squibb & Sons, Inc. 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts
JPS601162A (ja) * 1983-06-17 1985-01-07 Dai Ichi Seiyaku Co Ltd 3―アジド―2―オキソアゼチジン―1―スルホン酸誘導体の製造法
US4587051A (en) * 1983-07-18 1986-05-06 E. R. Squibb & Sons, Inc. Desulfonation process for preparing 2-azetidinones
US4596777A (en) * 1983-08-10 1986-06-24 E. R. Squibb & Sons, Inc. Process for preparing (3S)-3-[[[2-(protected or unprotected amino)-4-thiazolyl]acetyl]amino]-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives thereof
US4551277A (en) * 1983-11-09 1985-11-05 E. R. Squibb & Sons, Inc. 4-(3-Acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid
JPS60112789A (ja) * 1983-11-21 1985-06-19 Otsuka Chem Co Ltd 3−アシルアミノ−4−アルキル−2−アゼチジノン−1−スルホン酸誘導体、その製造方法および該誘導体を含有する薬剤
JPS60226855A (ja) * 1984-04-26 1985-11-12 Nippon Kayaku Co Ltd N−ベンジルオキシカルボニル−l−スレオニンアミド・1/2水和物およびその製造法
US4771135A (en) * 1984-05-22 1988-09-13 Eli Lilly And Company Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor
US4918185A (en) * 1984-05-22 1990-04-17 Eli Lilly And Company Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor
US4610824A (en) * 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US4680409A (en) * 1984-10-09 1987-07-14 E. R. Squibb & Sons, Inc. Hydrazide containing derivatives of 2-amino-4-thiazole-acetic acid
US4647660A (en) * 1985-05-02 1987-03-03 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
US4632985A (en) * 1985-06-03 1986-12-30 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
US4754041A (en) * 1985-06-17 1988-06-28 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
US4638062A (en) * 1985-06-17 1987-01-20 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
FR2588867B1 (fr) * 1985-10-23 1988-12-09 Roussel Uclaf Nouveaux produits derives de la serie de la 3-amino 2-oxo azetidine, leur procede de preparation et leur application
MX2007000526A (es) * 2005-05-09 2007-03-28 Sicor Inc Proceso para elaborar aztreonam.
JP5648250B2 (ja) * 2007-11-21 2015-01-07 国立大学法人東京工業大学 スルホン化含窒素複素環を有する高分子有機化合物および有機化合物、それらの製造方法、およびそれらを用いたイオン交換体、電解質膜、医薬品、触媒、膜電極接合体、燃料電池
EP2804589A1 (de) 2012-01-16 2014-11-26 Mahmut Bilgic Pharmazeutische formulierungen mit aztreonam
PL3122745T3 (pl) 2014-03-24 2019-08-30 Novartis Ag Monobaktamowe związki organiczne do leczenia zakażeń bakteryjnych
DK3353175T3 (da) 2015-09-23 2020-09-14 Novartis Ag Salte og faste former af et monobactam-antibiotikum
WO2019026004A2 (en) 2017-08-02 2019-02-07 Novartis Ag CHEMICAL PROCESS FOR THE PREPARATION OF ANTIBIOTIC MONOBACTAM AND ITS INTERMEDIATES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6046955B2 (ja) * 1977-12-30 1985-10-18 武田薬品工業株式会社 抗生物質g−6302
JPS55164672A (en) * 1979-06-08 1980-12-22 Takeda Chem Ind Ltd Azetidine derivative and its preparation
EP0021678B1 (de) * 1979-06-08 1984-11-07 Takeda Chemical Industries, Ltd. 1-Sulfo-2-azetidinon-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
JPS57131758A (en) * 1980-12-05 1982-08-14 Takeda Chem Ind Ltd 1-sulfo-2-oxoazetidine derivative, its preparation and use

Also Published As

Publication number Publication date
AU569407B2 (en) 1988-01-28
IE810230L (en) 1981-08-07
AU6698581A (en) 1981-08-13
HK57785A (en) 1985-08-09
IL62082A (en) 1986-08-31
GB8333191D0 (en) 1984-01-18
DK166280B (da) 1993-03-29
NO170015B (no) 1992-05-25
DE3104145A1 (de) 1981-12-17
DE3104145C2 (de) 1999-05-12
FI80271C (fi) 1990-05-10
IT1135360B (it) 1986-08-20
DK52381A (da) 1981-08-08
PH24729A (en) 1990-10-01
NO161065C (no) 1989-06-28
CA1338670C (en) 1996-10-22
DD156180A5 (de) 1982-08-04
IT8119587A0 (it) 1981-02-06
JPH0623188B2 (ja) 1994-03-30
YU44829B (en) 1991-04-30
SE457954B (sv) 1989-02-13
LU83117A1 (fr) 1982-09-10
FR2509299B1 (fr) 1985-08-30
KE3539A (en) 1985-07-12
NL192924B (nl) 1998-01-05
NO810410L (no) 1981-08-10
GR74151B (de) 1984-06-06
MY8600179A (en) 1986-12-31
SE8100861L (sv) 1981-08-08
GB2071650A (en) 1981-09-23
JPH0586023A (ja) 1993-04-06
KR830005131A (ko) 1983-08-03
SE8602193D0 (sv) 1986-05-14
IE51392B1 (en) 1986-12-24
SE8602193L (sv) 1986-05-14
FR2509299A1 (fr) 1983-01-14
IE862297L (en) 1981-08-07
GB2071650B (en) 1984-12-05
PH23316A (en) 1989-07-14
JPH0670006B2 (ja) 1994-09-07
PH23317A (en) 1989-07-14
JPS56125362A (en) 1981-10-01
SE8602194L (sv) 1986-05-14
NL8100571A (nl) 1981-09-01
NO860225L (no) 1981-08-10
SE500216C2 (sv) 1994-05-09
FI810352L (fi) 1981-08-08
PT72465B (en) 1982-02-04
CH651020A5 (de) 1985-08-30
IL62082A0 (en) 1981-03-31
SG39185G (en) 1985-12-13
ES499171A0 (es) 1982-06-01
KR860001289B1 (ko) 1986-09-10
GB2139618A (en) 1984-11-14
GB2139618B (en) 1985-05-01
IE51393B1 (en) 1986-12-24
AR245932A1 (es) 1994-03-30
AU4574885A (en) 1985-11-07
NO170015C (no) 1992-09-02
ES8205397A1 (es) 1982-06-01
NZ196202A (en) 1984-07-31
DK166280C (da) 1993-08-30
CH653993A5 (de) 1986-01-31
AU548896B2 (en) 1986-01-09
NZ205240A (en) 1984-07-31
SE8602194D0 (sv) 1986-05-14
YU31981A (en) 1984-02-29
FI80271B (fi) 1990-01-31
PT72465A (pt) 1981-03-01
JPH02160764A (ja) 1990-06-20
NO161065B (no) 1989-03-20

Similar Documents

Publication Publication Date Title
NL192924C (nl) ß-Lactamverbindingen met anti-biotische werking en bereiding daarvan.
EP0051381B1 (de) 0-Sulfatierte beta-Lactamhydroxamsäuren
US4775670A (en) 2-oxo-1-azetidinesulfonic acid salts
US4794108A (en) 1-carboxymethoxy acetidinones and their production
EP0048953B1 (de) Beta-Lactam-Antibiotika
EP0138407A1 (de) Azetidinone
MXPA06013456A (es) Metodo para producir derivados de 1,4-difenilazetidinona.
IE55839B1 (en) Azetidine compounds
EP0061765B1 (de) Beta-Laktame
US4529698A (en) Process for preparing a 2-oxo-1-azetidinesulfonic acid salt
US4533660A (en) Antibacterial O-sulfated β-lactam hydroxamic acids
US4478749A (en) 2-Oxo-1-(substituted phosphorous)azetidines
SU1272981A3 (ru) Способ получени @ -лактамов (его варианты)
US4647558A (en) Antibacterial agents, their preparation and use
EP0001715A2 (de) Azetidinon Antibiotika und ihre pharmazeutischen Präparate und Verwendung
US4416817A (en) 3-Methoxy-2-oxoazetidine derivatives and their production
JPH0780840B2 (ja) 4,4‐ジアルキル‐2‐アゼチジノン類の製造法
EP0256763B1 (de) Verfahren zur Herstellung von Azetidinonen
EP0187355A1 (de) Verfahren zur Herstellung von beta-Lactam-Antibiotika
JP2696807B2 (ja) カルバペネム誘導体の製法
HU190507B (en) Process for production of azetidinil sulpfon acids and analogic substances
US4444771A (en) Azeto triazolo pyrazine β-lactam antibacterial agents
US4670554A (en) ((3-Acylamino-2-oxo-1-azetidinyl)oxy)methyl)phosphinic acids
US4551276A (en) 2-Oxoazetidin-1-yloxymethyl sulfonic acid and analogs
US4883869A (en) Novel beta-lactams containing amino acid substituents

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010206